Parent Briefing: Independent Review Affirms Flu, RSV, and COVID Protection for Infants — Clinic Asks for October 15, 2026

Parent Briefing — October 15, 2026

An independent evidence review released this week by the Vaccine Integrity Project and the American Medical Association confirms that influenza, RSV, and COVID-19 immunizations continue to protect infants and children from severe illness and hospitalization.

Key numbers

• Flu vaccine ~80% effective against pediatric flu death.
• Maternal vaccines (flu, COVID-19, RSV) pass protection to infants in the first months.
• Nirsevimab reduces RSV hospitalization by roughly 64–93% in the first season.

What to ask at your next clinic visit

• If pregnant: timing for maternal flu, COVID-19, and RSV vaccines this season.
• If your baby is under 8 months: eligibility for nirsevimab (especially if maternal RSV vaccine was not received).
• Household flu and COVID-19 vaccination status.

Also this week

• Pennsylvania measles outbreak remains active (1,222+ cases reported); keep MMR status current for eligible household members.
• Continue checking formula pantry for any leftover recalled ByHeart or Nara Organics products linked to the earlier botulism investigation.

Information only — not medical advice. Discuss with your care team.